Amphastar Poised To Receive $59.9m In Momenta/Sandoz Settlement
The small generic drug company has talked about using the cash windfall from the expected settlement to fund clinical trials and possibly M&A.
The small generic drug company has talked about using the cash windfall from the expected settlement to fund clinical trials and possibly M&A.